China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.
Against a backdrop of rising U.S.-China geopolitical tensions, there are signs of growing dealmaking activity between Western ...
A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...
Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...
不过,上周一,中国创新药企创响生物(Inmagene Biopharmaceuticals)与美国医药企业 Ikena Oncology(IKNA.US)达成合并协议,创响生物通过反向收购的方式借道登上美股舞台,开启中国 Biotech 出海的新模式。 Ikena表示,此次合并交易预计将带来约1.75亿美元(12.77亿元)的资金 ...
Hong Kong-listed Chinese biotech firm New Horizon Health said its chairman and CEO stepped down amid turmoil at the company, which has been accused by a short seller of inflating its sales figures.
Beijing biotech Sironax has closed a whopping $200 ... inhibitors despite setbacks for GSK in the class. The five-year-old Chinese company – which is developing drugs for age-related ...
The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Ben Hargreaves ...
After genetic transformation, "super giant reed", a bamboo-like grass, has become a high-yield renewable resource, according to a Chinese biotech company. This "super giant reed", an improved ...
This has all had negative effects on American companies, but Chinese interference in biotechnology also presents national security risks for the United States as a whole. The Senate has an ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I’m still recovering from yesterday, when Chicago was ...